The impact of unfractionated heparin or bivalirudin on patients with stable coronary artery disease undergoing percutaneous coronary intervention.
Fabio V LimaLuis GrubergUsman AslamMelissa RamgadooKydanis ClaseAlessandra TrevisanAllen JeremiasPublished in: Journal of interventional cardiology (2017)
Among patients with stable angina or silent ischemia, there was no difference between UFH and bivalirudin in bleeding rates up to 30-days post-PCI. MACCE and NACE were higher among the bivalirudin group. Radial access was associated with a numerically lower rate of bleeding compared with femoral access.
Keyphrases
- percutaneous coronary intervention
- coronary artery disease
- st segment elevation myocardial infarction
- atrial fibrillation
- st elevation myocardial infarction
- acute myocardial infarction
- antiplatelet therapy
- coronary artery bypass grafting
- acute coronary syndrome
- cardiovascular events
- coronary artery bypass
- venous thromboembolism
- heart failure